Nothing to report....same old same old, it'll come out when it comes out:
First my email to IR
Sent: December 6, 2019 11:10 AM
To: RVX Investor Relations; Paul Moon
Subject: A question, hoping you can answer...
Same preface as other recent inquiries.....if you're unable to answer I understand, any light you can shed though is appreciated.
With respect to eGFR data, are you able to give any indication as to when shareholders should expect information for the CKD patients in BETonMACE?
Gordon
And the reply:
Hello Gordon: Don has already presented the CVD endpoints for the CKD subgroup in his Nov. 18th webcast. Analysis on related biomarkers in this subgroup continues and is expected to be shared in future publications and conferences.
Best regards,
RVX IR
